Healon

DEVICE2 trials

Sponsors

Alcon Research, LCA Pharmaceutical

Conditions

CataractCataract Surgery

Phase 4

To Compare the Ability of DiscoVisc® OVD to Protect the Corneal Endothelium and Maintain Anterior Chamber Space With Healon® and Amvisc® PLUS During Cataract Surgery.

CompletedNCT00763360

Alcon ResearchCataract

Start: 2008-05-31Updated: 2012-01-24

Unknown Phase

Clinical Investigation of IXIUM TWIN Viscoelastic Ophthalmic Device For Cataract Surgery

Not yet recruitingNCT07279506

LCA PharmaceuticalCataract Surgery

Start: 2026-01-31End: 2026-09-30Target: 180Updated: 2025-12-12